anti EBNA3 car t from Creative Biolabs that has expanded to the entire new drug discovery and development pipeline, including early discovery, preclinical testing, process development, cGMP manufacturing, phase 249-III clinical trials. https://www.creative-biolabs.com/car-t/target-ebna3-112.htm